Insider Transactions in Q3 2023 at Sensei Biotherapeutics, Inc. (SNSE)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2023
|
John Celebi PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.45%
|
$0
$0.85 P/Share
|
|
Jul 31
2023
|
Cambrian Bio Pharma Inc |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,587,302
-30.29%
|
$1,587,302
$1.26 P/Share
|
|
Jul 31
2023
|
James Peyer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,587,302
-30.29%
|
$1,587,302
$1.26 P/Share
|
|
Jul 10
2023
|
Samuel Broder Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,466
+33.33%
|
-
|
|
Jul 10
2023
|
Thomas G Ricks |
BUY
Grant, award, or other acquisition
|
Direct |
4,466
+33.33%
|
-
|
|
Jul 10
2023
|
William R Ringo |
BUY
Grant, award, or other acquisition
|
Direct |
4,466
+16.03%
|
-
|
|
Jul 10
2023
|
Kristian Humer |
BUY
Grant, award, or other acquisition
|
Direct |
4,466
+33.33%
|
-
|
|
Jul 10
2023
|
Deneen Vojta |
BUY
Grant, award, or other acquisition
|
Direct |
4,466
+33.33%
|
-
|
|
Jul 10
2023
|
Jessie English |
BUY
Grant, award, or other acquisition
|
Direct |
4,466
+33.33%
|
-
|
|
Jul 10
2023
|
Bob Holmen |
BUY
Grant, award, or other acquisition
|
Direct |
4,466
+14.86%
|
-
|
|
Jul 10
2023
|
Cambrian Bio Pharma Inc |
BUY
Grant, award, or other acquisition
|
Direct |
4,466
+0.09%
|
-
|
|
Jul 10
2023
|
James Peyer |
BUY
Grant, award, or other acquisition
|
Indirect |
4,466
+0.09%
|
-
|